argenx SE
XBRU:ARGX
argenx SE
XBRU:ARGX
Price:
366.6 EUR
0.88%
Market Closed
Updated:
May 8, 2024
argenx SE
Revenue
|
argenx SE
Revenue Peer Comparison
Comparables:
PHARM
PRQR
QURE
MRUS
N
NAMS
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
argenx SE
XBRU:ARGX
|
Revenue
$1.2B
|
CAGR 3-Years
210%
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
|
Pharming Group NV
AEX:PHARM
|
Revenue
$245.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
43%
|
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Revenue
€9.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Uniqure NV
NASDAQ:QURE
|
Revenue
$15.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
|
Merus NV
NASDAQ:MRUS
|
Revenue
$43.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Revenue
€97.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
argenx SE
Revenue Breakdown
Breakdown by Geography
argenx SE
argenx SE
|
Total Revenue:
1.2B
USD
|
|
United States:
377.7m
USD
|
|
Japan:
15.8m
USD
|
|
Europe:
5.7m
USD
|
Breakdown by Segments
argenx SE
argenx SE
Not Available
See Also
What is argenx SE's Revenue?
Revenue
1.2B
USD
1.2B
USD
Based on the financial report for Dec 31, 2023, argenx SE's Revenue amounts to 1.2B USD.
What is argenx SE's Revenue growth rate?
Revenue CAGR 5Y
121%
121%
Over the last year, the Revenue growth was 199%. The average annual Revenue growth rates for argenx SE have been 210% over the past three years , 121% over the past five years .
You don't have any saved screeners yet
